Not Tagged
Not Tagged
['gyn', 'ovarian']
 folr1 is folate receptor alpha and mirvetixumab is an adc: folate receptor alpha directed antibody and microtubule inhibitor conjugate! already fda approved but the os data is huge!!! #gyncsm #ovariancancer #asco23
Breast & gyn med onc @valleyhealthnj. Opinions my own. RT not endorsements. Host of INTERLUDE podcast 🎤 ASCO FCOI= https://t.co/C54erlhQe8